- Home
- DSGN vs FDBC Comparison
DSGN vs FDBC Comparison
Compare DSGN & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- FDBC
- Stock Information
- Founded
- DSGN 2017
- FDBC 1902
- Country
- DSGN United States
- FDBC United States
- Employees
- DSGN N/A
- FDBC N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- DSGN Health Care
- FDBC Finance
- Exchange
- DSGN Nasdaq
- FDBC Nasdaq
- Market Cap
- DSGN 208.9M
- FDBC 234.2M
- IPO Year
- DSGN 2021
- FDBC N/A
- Fundamental
- Price
- DSGN $5.85
- FDBC $45.48
- Analyst Decision
- DSGN
- FDBC
- Analyst Count
- DSGN 0
- FDBC 0
- Target Price
- DSGN N/A
- FDBC N/A
- AVG Volume (30 Days)
- DSGN 167.2K
- FDBC 7.1K
- Earning Date
- DSGN 11-06-2025
- FDBC 10-22-2025
- Dividend Yield
- DSGN N/A
- FDBC 3.50%
- EPS Growth
- DSGN N/A
- FDBC 49.33
- EPS
- DSGN N/A
- FDBC 4.10
- Revenue
- DSGN N/A
- FDBC $84,975,000.00
- Revenue This Year
- DSGN N/A
- FDBC N/A
- Revenue Next Year
- DSGN N/A
- FDBC N/A
- P/E Ratio
- DSGN N/A
- FDBC $11.20
- Revenue Growth
- DSGN N/A
- FDBC 20.65
- 52 Week Low
- DSGN $2.60
- FDBC $37.00
- 52 Week High
- DSGN $7.77
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- DSGN 55.18
- FDBC 52.21
- Support Level
- DSGN $5.65
- FDBC N/A
- Resistance Level
- DSGN $6.65
- FDBC $47.54
- Average True Range (ATR)
- DSGN 0.49
- FDBC 1.07
- MACD
- DSGN -0.05
- FDBC -1.58
- Stochastic Oscillator
- DSGN 50.40
- FDBC 95.67
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.